The CTSA program at NIH : opportunities for advancing clinical and translational research

Author / Creator

Institute of Medicine (U.S.). Committee To Review the Clinical and Translational Science Awards at the National Center for Advancing Translational Sciences

Available as

Online

Summary

"The NIH contracted with the Institute of Medicine (IOM) in 2012 to conduct a study to assess and provide recommendations on appropriateness of the CTSA Program's mission and strategic goals and wh...

"The NIH contracted with the Institute of Medicine (IOM) in 2012 to conduct a study to assess and provide recommendations on appropriateness of the CTSA Program's mission and strategic goals and whether changes were needed. The committee was also tasked with providing an independent appraisal of and advice on the implementation of the program by the National Center for Advancing Translational Sciences (NCATS), while exploring the contributions of CTSAs in accelerating the development of new therapeutics, facilitating disease-specific and child health research, and enhancing the integration of research funded by NIH institutes and centers. To conduct this study, the IOM convened a 13-member committee with expertise in community outreach and engagement, public health and health policy, bioethics, education and training, pharmaceutical research and development, program evaluation, clinical and biomedical research, and child health research, along the full continuum of clinical and translation research. The committee's overarching conclusion is that the CTSA Program is contributing significantly to the advancement of clinical and translational research and is therefore a worthwhile investment that would benefit from a variety of revisions to make it more efficient and effective"--

Show More